Use of NOAC in clinical practice of stroke: Expert Opinion of the Turkish Society of Cerebrovascular Diseases
It is clear that nonvitamin K oral anticoagulants (NOACs) have been used successfully for more than ten years to prevent stroke in atrial fibrillation. In addition to the fact that they cause significantly less bleeding compared to warfarin and can prevent stroke equally or more, their easy-to-use f...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkish Society of Cerebrovascular Diseases
2020-12-01
|
Series: | Türk Beyin Damar Hastalıkları Dergisi |
Subjects: | |
Online Access: | https://www.journalagent.com/z4/download_fulltext.asp?pdir=tbdhd&un=TBDHD-26213 |